News & Announcements

Join Dr. Carrie Richardson for a free virtual Scleroderma 101 meeting hosted by the Scleroderma Foundation of Greater Chicago.

We are excited to introduce Dr. Carrie Richardson as the new Co-Director of the Northwestern Scleroderma Program.  In addition to caring for scleroderma patients, she will be serving as Principal Investigator for ongoing scleroderma clinical trials and the CONQUER registry.  

Dr. Richardson is originally from Oak Lawn, Illinois and completed her undergraduate training at Harvard University. As a medical student and then as a resident at Northwestern University, she worked closely with the Northwestern Scleroderma Program.   Very early in her residency, she decided to become a rheumatologist specifically to help to develop new treatments for scleroderma. She then moved to Baltimore to complete her rheumatology fellowship training at Johns Hopkins University.  While at Johns Hopkins she also obtained a Master of Health Science degree from the Bloomberg School of Public Health through the Graduate Training Program in Clinical Investigation.

Dr. Richardson’s primary clinical interests are scleroderma and myositis.  Her research has focused on mechanisms of calcinosis in scleroderma.  She has published a variety of peer-reviewed journal articles in topics ranging from autoantibodies to interstitial lung disease.  Dr. Richardson's expertise in scleroderma and other complex autoimmune disorders will be invaluable to our patients, and we are thrilled that she has joined our program.   

To schedule an appointment with Dr. Richardson, please contact Julie Holly, Scleroderma Patient Liaison, at 312-695-6119.